University of Cincinnati — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University of Cincinnati appears in 106 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials106

Recruiting shown6

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)NCT07528638 · lead sponsor · 2026-06-29

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic DomainsNCT06795451 · lead sponsor · 2025-02-25

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral BlocksNCT06574022 · lead sponsor · 2024-09-25

Effect of C-peptide on Hypoglycemic CounterregulationNCT06470295 · lead sponsor · 2024-06-01

Hormonal Responses to a Mixed Meal in People With Cystic FibrosisNCT06163482 · lead sponsor · 2023-03-28

Safety and Durability of Sirolimus for Treatment of LAMNCT02432560 · lead sponsor · 2015-03-01

Healthy Eating for My Infant: A Community- Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and FeedingNCT07284108 · lead sponsor · 2026-01-29

ENROLLING_BY_INVITATION

CanRestoreFunction Cancer-related Fatigue ( CRF )NCT05868187 · lead sponsor · 2023-03-01

Evaluation of Perforator Phase Contrast Angiography in Developing Surgery Plans for Patients With Breast Cancer Undergoing Breast Reconstruction With Free-Flap Methods After MastectomyNCT04063410 · lead sponsor · 2023-01-01

iCan Diabetes Self-management and Prevention ProgramNCT05571436 · lead sponsor · 2022-10-17

Healthy Eating for My Infant (HEMI)NCT04977947 · lead sponsor · 2022-06-06

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantNCT05027425 · lead sponsor · 2021-12-07

HRV as a Marker of Treatment Response in PAH Arterial HypertensionNCT04451850 · lead sponsor · 2021-06-01

Proton Accelerated Partial Breast IrradiationNCT03940248 · lead sponsor · 2020-07-01

Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)NCT04352621 · lead sponsor · 2020-05-01

Effect of Fasting on Hypoglycemic Counterregulation in Type 1 DiabetesNCT05973799 · lead sponsor · 2019-10-10

CCR5-modified CD4+ T Cells for HIV InfectionNCT03666871 · lead sponsor · 2019-06-12

Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk ReductionNCT03895580 · lead sponsor · 2019-04-08

Cervical Ripening in Obese Women: Efficacy of 25 mcg Versus 50 mcg of MisoprostolNCT03748147 · lead sponsor · 2018-12-10

Healthy Start to Feeding InterventionNCT03597061 · lead sponsor · 2018-11-01

Spinal Cord Stimulation for the Treatment of Major Depressive DisorderNCT03433339 · lead sponsor · 2018-08-29

Proton Boost in Prostate CancerNCT03564275 · lead sponsor · 2018-04-16

ACTIVE_NOT_RECRUITING

Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer SurvivorsNCT03257670 · lead sponsor · 2018-03-20

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate CancerNCT03960788 · lead sponsor · 2018-01-02

RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV TestingNCT03411265 · lead sponsor · 2017-11-08

AWAITS: A Web-based E-health Application for Active Illicit Opioid UsersNCT03402672 · lead sponsor · 2017-11-08

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBGNCT03227393 · lead sponsor · 2017-09-30

Budesonide for Liver Transplant Immune SuppressionNCT03304626 · lead sponsor · 2017-06-27

Early Intervention in Cognitive AgingNCT02751866 · lead sponsor · 2016-01-01

ACTIVE_NOT_RECRUITING

Treating Bacterial Overgrowth in Parkinson's DiseaseNCT02470780 · lead sponsor · 2015-12-01

Exhaled Carbon Monoxide and Red Blood Cell TurnoverNCT03288233 · lead sponsor · 2015-04-01

Riociguat for Sarcoidosis Associated Pulmonary HypertensionNCT02625558 · lead sponsor · 2015-04-01

Pericardial Fat and Inflammation in HIV Patients and ControlsNCT02399384 · lead sponsor · 2015-01-14

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CTNCT02119065 · lead sponsor · 2014-01-30

ACTIVE_NOT_RECRUITING

SGA-induced Metabolic Syndrome in Bipolar YouthNCT01858948 · lead sponsor · 2013-07-01

Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart FailureNCT01814319 · lead sponsor · 2013-03-01

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)NCT01467791 · lead sponsor · 2011-11-01

Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus DiureticsNCT01457053 · lead sponsor · 2011-11-01

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected PatientsNCT01335230 · lead sponsor · 2011-04-01

Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean DeliveryNCT01194115 · lead sponsor · 2010-09-01

Hypertonic Saline vs. Mannitol for Elevated Intercranial PressureNCT01111682 · lead sponsor · 2010-04-01

Challenging the Gold Standard: Pilot Study Comparing Continuous Glucose Monitoring System (CGMS), Capillary Glucose Monitors and 3 Hour Glucose Tolerance Test (GTT) to Diagnose Gestational Diabetes Mellitus (GDM)NCT01074489 · lead sponsor · 2010-02-01

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast CancerNCT00981812 · lead sponsor · 2009-09-01

Observational Study of Cortical Spreading Depression in Human Brain TraumaNCT00803036 · lead sponsor · 2009-01-01

Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic StudyNCT00885495 · lead sponsor · 2009-01-01

Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese AdultsNCT00845507 · lead sponsor · 2008-12-01

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary HypertensionNCT00581607 · lead sponsor · 2008-04-01

Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk ReductionNCT00609089 · lead sponsor · 2008-03-01

Modifying Dietary Behavior in Adolescents With Elevated Blood PressureNCT00585832 · lead sponsor · 2008-02-01

Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation AnalysisNCT00875940 · lead sponsor · 2008-02-01

Omega-3 Fatty Acid Deficiency Replacement in Early SchizophreniaNCT00585390 · lead sponsor · 2008-01-01

Methylphenidate for the Treatment of Gait Impairment in Parkinson's DiseaseNCT00526630 · lead sponsor · 2007-12-01

Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical TreatmentNCT00558532 · lead sponsor · 2007-10-01

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate CancerNCT01653093 · lead sponsor · 2007-09-20

ACTIVE_NOT_RECRUITING

Sympathetic Nervous System Modulation in HypertensionNCT00491387 · lead sponsor · 2007-08-01

Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive DisorderNCT00511810 · lead sponsor · 2007-08-01

Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical FeaturesNCT00585585 · lead sponsor · 2007-07-01

Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's DiseaseNCT00477802 · lead sponsor · 2007-05-01

Inhaled Iloprost for Sarcoidosis-associated Pulmonary HypertensionNCT00403650 · lead sponsor · 2006-11-01

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia PatientsNCT00375557 · lead sponsor · 2006-10-01

Sponsor roles

lead sponsor67

collaborator39

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.